Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

This study has been completed.
Sponsor:
Collaborators:
Minneapolis Veterans Affairs Medical Center
Minnesota Veterans Research Institute
InterMune
Kadmon Pharmaceuticals
San Diego Veterans Healthcare System
Information provided by:
Minneapolis Veterans Affairs Medical Center
ClinicalTrials.gov Identifier:
NCT00211692
First received: September 13, 2005
Last updated: February 17, 2011
Last verified: September 2005